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Available online 13 July 2011The quest for a useful prognostic biomarker of abdominal
aortic aneurysm (AAA) expansion and rupture is under way.
Several proteins have been tested but so far none have
been definitely established. Different investigations have
looked into the circulating expression of inflammation,
collagen breakdown, extracellular matrix degeneration,
coagulation and fibrinolysis, etc.1e3 Ramazani et al4 focus
on a slightly different approach, the assessment of circu-
lating levels of basement membrane fragments. They found
increased concentrations of both circulating type IV and
XVIII collagen in AAA patients compared to controls, sug-
gesting enhanced basement membrane destruction in the
vessel wall of the former. Pathogenesis of arterial occlusive
disease seems to be somewhat different, however, as no
significant differences were found for both protein levels
between PAD patients and controls. The findings are
interesting but still very preliminary. This pilot study was
performed in a very small sample and no evaluation of AAA
size or growth was done. The authors have begun a new line
of investigation which has yet to yield any hopeful results.
The establishment of a useful biomarker is not an easy task.
It is not clear whether circulating levels of a given protein
accurately reflect the corresponding tissue activity. It is also
unclear whether the protein fragments are released into the
circulation during the initial or late stages of the proteolytic
activity. If the circulating levels were to increase at theDOI of original article: 10.1016/j.ejvs.2011.05.021.
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could help predict short-termevolution of theAAA.However, if
the increasedcirculating levelsof thepotentialbiomarkerwere
registered after the AAA had already expanded, the prognostic
value of the biomarker would be invalidated, as the expansion
can be easily detected a posteriori with ultrasound or CT
scanning. Still, the prognosis of AAA growth and rupture risk is
not the only potential use of the different studied biomarkers;
they could offer interesting data of the effect of future phar-
macological agents for the treatment of AAA. All in all, it is
doubtful that a sole circulating biomarker will be accurate
enough to be, on its own, applicable in clinical practice. It is
more likely that a combination of circulating proteins and
image techniques will be required to predict AAA behaviour.
Different lines of investigation are working in this direction.
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